Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;35(7):839-44.
doi: 10.1086/676859. Epub 2014 May 9.

Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians

Michael A Lane  1 , Jonas Marschall, Susan E Beekmann, Philip M Polgreen, Ritu Banerjee, Adam L Hersh, Hilary M Babcock
Affiliations

Outpatient parenteral antimicrobial therapy practices among adult infectious disease physicians

Michael A Lane et al. Infect Control Hosp Epidemiol. 2014 Jul.

Abstract

Objective: To identify current outpatient parenteral antibiotic therapy practice patterns and complications.

Methods: We administered an 11-question survey to adult infectious disease physicians participating in the Emerging Infections Network (EIN), a Centers for Disease Control and Prevention-sponsored sentinel event surveillance network in North America. The survey was distributed electronically or via facsimile in November and December 2012. Respondent demographic characteristics were obtained from EIN enrollment data.

Results: Overall, 555 (44.6%) of EIN members responded to the survey, with 450 (81%) indicating that they treated 1 or more patients with outpatient parenteral antimicrobial therapy (OPAT) during an average month. Infectious diseases consultation was reported to be required for a patient to be discharged with OPAT by 99 respondents (22%). Inpatient (282 [63%] of 449) and outpatient (232 [52%] of 449) infectious diseases physicians were frequently identified as being responsible for monitoring laboratory results. Only 26% (118 of 448) had dedicated OPAT teams at their clinical site. Few infectious diseases physicians have systems to track errors, adverse events, or "near misses" associated with OPAT (97 [22%] of 449). OPAT-associated complications were perceived to be rare. Among respondents, 80% reported line occlusion or clotting as the most common complication (occurring in 6% of patients or more), followed by nephrotoxicity and rash (each reported by 61%). Weekly laboratory monitoring of patients who received vancomycin was reported by 77% of respondents (343 of 445), whereas 19% of respondents (84 of 445) reported twice weekly laboratory monitoring for these patients.

Conclusions: Although use of OPAT is common, there is significant variation in practice patterns. More uniform OPAT practices may enhance patient safety.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest: All authors report no conflicts of interest relevant to this article.

Figures

Figure 1
Figure 1
Number of respondents reporting perceived frequency of specified OPAT Complications * DVT – Deep vein thrombosis.
Figure 2
Figure 2
Number of respondents reporting perceived frequency of specified consequences of OPAT Complications
See this image and copyright information in PMC

References

    1. Leder K, Turnidge JD, Grayson ML. Home-based treatment of cellulitis with twice-daily cefazolin. The Medical journal of Australia. 1998;169(10):519–522. - PubMed
    1. Nathwani D. The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom. Chemotherapy. 2001;47(Suppl 1):17–23. - PubMed
    1. Eron LJ, Goldenberg RI, Poretz DM. Combined ceftriaxone and surgical therapy for osteomyelitis in hospital and outpatient settings. Am J Surg. 1984;148(4A):1–4. - PubMed
    1. Tice AD. Outpatient parenteral antimicrobial therapy for osteomyelitis. Infect Dis Clin North Am. 1998;12(4):903–919. - PubMed
    1. Esposito S, Noviello S, Leone S, et al. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents. 2004;24(5):473–478. - PubMed

Publication types

Substances